Quantcast

Latest Autoimmunity Stories

2014-09-17 08:31:07

-Enhances Capabilities for the Precision Medicine in Immuno-oncology and Autoimmune Disease Areas- LOS ANGELES and LEIPZIG, Germany, Sept. 17, 2014 /PRNewswire/ -- ImaginAb, Inc. today announced that it has entered into an exclusive technology development partnership with Novotectid GmbH for the development of antibody-based imaging agents to image CD4+ positive immune T cells. "Our collaboration with Novotectid expands ImaginAb's capability to precisely diagnose and determine...

2014-09-15 12:27:50

Hundreds Step Up For New Lupus Treatments NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Over 200 patients, families, physicians and scientists came together under one roof Saturday to learn, interact and participate in the drive for better lupus treatments at New York City's first Lupus Trials Fair launched by the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation. Attendees interacted directly with researchers at eight of NYC's leading institutions -- sharing experiences,...

2014-09-09 12:28:50

Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing WASHINGTON, Sept. 9, 2014 /PRNewswire-USNewswire/ -- Today, the Lupus Foundation of America, the only national force devoted to solving the mystery of lupus, and the Rheumatology Research Foundation, the largest private funding source of rheumatology research and training programs, convened on Capitol Hill to update our nation's leaders about the new Accelerating Medicines Partnership (AMP)...

macrophages engulf dead cells
2014-09-08 02:00:50

Salk Institute Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies. In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day. When these garbage disposals don’t do their job, dead cells and their waste products rapidly pile up, destroying healthy tissue and leading to autoimmune...

2014-09-08 08:31:19

SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, has exercised its option to acquire a novel antibody program from AnaptysBio. Upon payment of an option exercise fee to...

2014-09-04 12:26:34

DIEPENBEEK, Belgium, September 4, 2014 /PRNewswire/ -- Scientists discover how to 'switch off' autoimmune diseases Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that Bristol University research led by Apitope Founder and CSO, Prof David Wraith, on its treatment approach to autoimmune diseases, such as Multiple Sclerosis (MS), has been published...

2014-09-01 04:20:02

A*STAR scientists find new targets for modulating antibody response Singapore, Sept 1, 2014 - (ACN Newswire) - Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have uncovered the crucial role of two signalling molecules, DOK3 and SHP1, in the development and production of plasma cells. These discoveries, published in two prestigious journals PNAS and Nature Communications, advance the understanding of plasma cells and...

2014-08-27 12:30:09

Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology....

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-26 12:28:02

ANN ARBOR, Mich., Aug. 26, 2014 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company pioneering the development of breakthrough oral medicines to treat autoimmune disease and cancer based on the science of immune modulation, today announced the appointment of Harinder Singh, Ph.D., as chair of the company's scientific advisory board. Dr. Singh will lead the board's efforts to provide guidance and insight to advance Lycera's multiple ongoing research programs and pipeline of...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.